In pre-clinical in vivo mouse models of MPM, the dependency on heparanase for tumor growth was demonstrated in the context of heparanase gene disruption and in response to heparanase-inhibiting compounds (Barash et al., 2018; Lapidot et al., 2018). Here, HPSE is linked to neoplasm.